Home Medicine Exhaled carbon monoxide in adolescents with diabetic cardiovascular autonomic neuropathy
Article
Licensed
Unlicensed Requires Authentication

Exhaled carbon monoxide in adolescents with diabetic cardiovascular autonomic neuropathy

  • EMAIL logo , , , and
Published/Copyright: April 16, 2014

Abstract

The aim of the study was to determine if cardiovascular autonomic neuropathy (CAN) is associated with changed concentration of exhaled carbon monoxide (eCO) in adolescents with type 1 diabetes (T1D). A total of 46 T1D patients and 25 healthy controls (15–19 years) were enrolled. The parameters eCO and carboxyhemoglobin (HbCO) were established using a MICRO-4 Smokerlyser. CAN was examined by standard cardiovascular tests. Adolescents with T1D did not significantly differ in eCO compared to healthy subjects. eCO and HbCO were significantly lower in CAN-positive subjects (n=19) (1.36±1.65 ppm vs. 3.09±2.31, p=0.01 and 0.58±0.49% vs. 1.04±0.44, p<0.01, respectively) compared to CAN-negative subjects (n=27), whereas no significant difference was found in other measured parameters. By multivariate logistic regression, eCO and HbCO were associated with higher risk of CAN (OR=1.824, p<0.05 and OR=10.989, p<0.01). Our results indicate that eCO is decreased in CAN-positive diabetic subjects. Further studies are necessary to investigate the possible role of eCO as a marker for CAN.


Corresponding author: Jarmila Vojtková, MD, PhD, Department of Pediatrics, Jessenius Faculty of Medicine Comenius University and University Hospital Martin, Kollárova 2, 03601 Martin, Slovakia, Phone: +421 43 4203 254, Fax: +421 43 4222 678, E-mail:

Acknowledgments

The study was supported by project “Centre of Experimental and Clinical Respirology, CEKR II”, co-financed by EU sources.

References

1. Ziegler D, Dannehl K, Muhlen H, Spuler M, Gries FA. Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis and standard tests of heart-rate variation in newly diagnosed IDDM patients. Diabetes Care 1992;15:908–11.10.2337/diacare.15.7.908Search in Google Scholar PubMed

2. Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, et al. on behalf of the Toronto Consensus Panel on Diabetic Neuropathy. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011;27:639–53.10.1002/dmrr.1239Search in Google Scholar PubMed

3. Karavanaki-Karanassiou K. Autonomic neuropathy in children and adolescents with diabetes mellitus. J Pediatr Endocrinol Metab 2001;14(suppl 5):1379–86.Search in Google Scholar

4. Kumar A, Negi G, Sharma SS. Suppression of NF-κB and NF-κB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IκB phosphorylation inhibitor) in experimental diabetic neuropathy. Biochimie 2012;94:1158–65.10.1016/j.biochi.2012.01.023Search in Google Scholar PubMed

5. Ozer G, Teker Z, Cetiner S, Yilmaz M, Topaloglu AK, et al. Serum IL-1, IL-2, TNFalpha and INFgamma levels of patients with type 1 diabetes mellitus and their siblings. J Pediatr Endocrinol Metab 2003;16:203–10.10.1515/JPEM.2003.16.2.203Search in Google Scholar PubMed

6. Jesenak M, Babusikova E, Banovcin P. Carbon monoxide as a marker of lung diseases at the child age. Czech-Slovak Pediatrics 2006;61:651–6.Search in Google Scholar

7. Li M, Peterson S, Husney D, Inaba M, Guo K, et al. Interdiction of the diabetic state in NOD mice by sustained induction of heme oxygenase: possible role of carbon monoxide and bilirubin. Antioxid Redox Signal 2007;9:855–63.10.1089/ars.2007.1568Search in Google Scholar PubMed

8. Cheng S, Lyass A, Massaro JM, O’Connor GT, Keaney Jr JF, et al. Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community. Circulation 2010;122:1470–7.10.1161/CIRCULATIONAHA.110.941013Search in Google Scholar PubMed PubMed Central

9. Paredi P, Leckie MJ, Horvath I, Allegra L, Kharitonov SA, et al. Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma. Eur Respir J 1999;13:48–52.10.1183/09031936.99.13104899Search in Google Scholar PubMed

10. Tiwari S, Ndisang JF. The heme oxygenase system and type-1 diabetes. Curr Pharm Des 2014;20:1328–37.10.2174/13816128113199990552Search in Google Scholar PubMed

11. Babusikova E, Jesenak M, Durdik P, Dobrota D, Banovcin P. Exhaled carbon monoxide as a new marker of respiratory diseases in children. J Physiol Pharmacol 2008;59(suppl 6):9–17.Search in Google Scholar

12. Underner M, Peiffer G. Interpretation of exhaled CO levels in studies on smoking. Rev Mal Respir 2010;27:293–300.10.1016/j.rmr.2009.09.004Search in Google Scholar PubMed

13. Horvath I, Loukides S, Wodehouse T, Kharitonov SA, Cole PJ, et al. Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress. Thorax 1998;53:867–70.10.1136/thx.53.10.867Search in Google Scholar PubMed PubMed Central

14. Abd El Khalek KA, El Seify MY, Youssef OI, Badr MM. Diagnostic value of exhaled carbon monoxide as an early marker of exacerbation in children with chronic lung diseases. ISRN Pediatr 2012;2012:859873.10.5402/2012/859873Search in Google Scholar

15. Khaliq F, Parveen A, Singh S, Hussain ME, Fahim M. Terminalia arjuna improves cardiovascular autonomic neuropathy in streptozotocin-induced diabetic rats. Cardiovasc Toxicol 2013;13:68–76.10.1007/s12012-012-9187-6Search in Google Scholar

16. Opara EC, Abdel-Rahman E, Soliman S, Kamel WA, Souka S, et al. Depletion of total antioxidant capacity in type 2 diabetes. Metab 1999;48:1414–7.10.1016/S0026-0495(99)90152-XSearch in Google Scholar

17. Varechova S, Mikler J, Murgas D, Dragula M, Banovcin P, et al. Cough reflex sensitivity in children with suspected and confirmed gastroesophageal reflux disease. J Physiol Pharmacol 2007;58(suppl 5):717–27.Search in Google Scholar

18. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years’ experience in diabetes. Diabetes Care 1985;8:491–8.10.2337/diacare.8.5.491Search in Google Scholar PubMed

19. Havlicekova Z, Jurko A Jr. Heart rate variability changes in children after cardiac transplantation. Bratisl Lek Listy 2005;106:168–70.Search in Google Scholar

20. Tonhajzerová I, Javorka K, Javorka M, Petrásková M. Cardiovascular autonomic nervous system tests: reference values in young people (15–19 years) and influence of age and gender. Clin Physiol Funct Imaging 2002;22:398–403.10.1046/j.1475-097X.2002.00449.xSearch in Google Scholar PubMed

21. Son Y, Lee JH, Chung HT, Pae HO. Therapeutic roles of heme oxygenase-1 in metabolic diseases: curcumin and resveratrol analogues as possible inducers of heme oxygenase-1. Oxid Med Cell Longev. 2013;2013:639541. [Epub 2013 September 11].10.1155/2013/639541Search in Google Scholar PubMed PubMed Central

22. Mishra M, Ndisang JF. A critical and comprehensive insight on heme oxygenase and related products including carbon monoxide, bilirubin, biliverdin and ferritin in type-1 and type-2 diabetes. Curr Pharm Des 2014;20:1370–91.10.2174/13816128113199990559Search in Google Scholar PubMed

23. Kamboj SS, Vasishta RK, Sandhir R. N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy. J Neurochem 2010;112:77–91.10.1111/j.1471-4159.2009.06435.xSearch in Google Scholar PubMed

24. Vojtkova J, Čiljakova M, Durdik P, Michnova Z, Turcan T, et al. The influence of glutathione-S-transferase T1/M1 gene polymorphisms on biochemical parameters in children with type 1 diabetes. Pediatria (Bratisl.) 2012;7:70–4.Search in Google Scholar

25. Vojtkova J, Durdik P, Ciljakova M, Michnova Z, Turcan T, et al. The association between glutathione S-transferase T1 and M1 gene polymorphisms and cardiovascular autonomic neuropathy in Slovak adolescents with type 1 diabetes mellitus. J Diabetes Complications 2013;27:44–8.10.1016/j.jdiacomp.2012.07.002Search in Google Scholar PubMed

26. Murakami A, Fujimori Y, Yoshikawa Y, Yamada S, Tamura K, et al. Heme oxygenase-1 promoter polymorphism is associated with risk of malignant mesothelioma. Lung 2012;190:333–7.10.1007/s00408-012-9371-2Search in Google Scholar PubMed

27. Bean CJ, Boulet SL, Ellingsen D, Pyle ME, Barron-Casella EA, et al. Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease. Blood 2012;120:3822–8.10.1182/blood-2011-06-361642Search in Google Scholar PubMed PubMed Central

28. Fritsch T, van Herpen M, von Basum G, Hering P, Mürtz M. Is exhaled carbon monoxide level associated with blood glucose level? A comparison of two breath analyzing methods. J Biomed Opt 2008;13:034012.10.1117/1.2937215Search in Google Scholar PubMed

29. Paredi P, Biernacki W, Invernizzi G, Kharitonov SA, Barnes PJ. Exhaled carbon monoxide levels elevated in diabetes and correlated with glucose concentration in blood: a new test for monitoring the disease? Chest 1999;116:1007–11.10.1378/chest.116.4.1007Search in Google Scholar PubMed

30. Zivić S, Vlaski J, Kocić G, Pesić M, Cirić V, et al. The importance of oxidative stress in pathogenesis of type 1 diabetes – determination of catalase activity in lymphocytes of diabetic patients. Med Pregl 2008;61:458–63.10.2298/MPNS0810458ZSearch in Google Scholar

31. Hisalkar PJ, Patne AB, Fawade MM, Karnik AC. Evaluation of plasma superoxide dismutase and glutathione peroxidase in type 2 diabetic patients. Biol Med 2012;4:65–72.Search in Google Scholar

32. Yeh SY, Doupis J, Rahangdale S, Horr S, Malhotra A, et al. Total serum bilirubin does not affect vascular reactivity in patients with diabetes. Vasc Med 2009;14:129–36.10.1177/1358863X08098273Search in Google Scholar PubMed PubMed Central

33. Fukui M, Tanaka M, Shiraishi E, Harusato I, Hosoda H, et al. Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int 2008;74: 1197–201.10.1038/ki.2008.398Search in Google Scholar PubMed

34. Ciljakova M, Vojtkova J, Durdik P, Turcan T, Petrikova M, et al. Cough reflex sensitivity in adolescents with diabetic autonomic neuropathy. Eur J Med Res 2009;14(suppl 4):S45–8.10.1186/2047-783X-14-S4-45Search in Google Scholar

35. Ciljakova M, Vojtkova J, Vojarova L, Klabnikova K, Durdik P, et al. Risk factors of autonomic neuropathy in children with type 1 diabetes mellitus. Pediatria (Bratisl.) 2011;6:239–45.Search in Google Scholar

36. Court JM, Cameron FJ, Berg-Kelly K, Swift PGF. Diabetes in adolescence. Pediatr Diabetes 2009;10(suppl 12):185–94.10.1111/j.1399-5448.2009.00586.xSearch in Google Scholar PubMed

37. Abd El, Dayem SM, Battah AA, Soliman RA. Natural progression of cardiac autonomic neuropathy in patients with type 1 diabetes: a four-year follow-up study. Anadolu Kardiyol Derg 2011;11:224–31.Search in Google Scholar

38. Barkai L, Madácsy L. Cardiovascular autonomic dysfunction in diabetes mellitus. Arch Dis Child 1995;73:515–8.10.1136/adc.73.6.515Search in Google Scholar PubMed PubMed Central

39. Verrotti A, Loiacono G, Mohn A, Chiarelli F. New insights in diabetic autonomic neuropathy in children and adolescents. Eur J Endocrinol 2009;161:811–8.10.1530/EJE-09-0710Search in Google Scholar PubMed

Received: 2013-10-11
Accepted: 2014-2-28
Published Online: 2014-4-16
Published in Print: 2014-7-1

©2014 by Walter de Gruyter Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Welcome to Assistant Editors at JPEM
  4. Review article
  5. Common approach to childhood obesity in Japan
  6. Images in pediatric endocrinology
  7. Aromatase deficiency in an adolescent girl misdiagnosed as congenital adrenal hyperplasia in infancy and childhood
  8. Original articles
  9. Prevalence of vitamin D deficiency among Iranian adolescents
  10. Analysis of body composition among children and adolescents – a cross-sectional study of the Polish population and comparison of body fat measurement methods
  11. Association of rs8066560 variant in the sterol regulatory element-binding protein 1 (SREBP-1) and miR-33b genes with hyperglycemia and insulin resistance
  12. Differences in anxiety and depression between male and female caregivers of children with a disorder of sex development
  13. Fasting and postprandial levels of a novel anorexigenic peptide nesfatin in childhood obesity
  14. The effect of growth hormone treatment on height in children with idiopathic short stature
  15. Clinical characteristics of type 1 diabetes over a 40 year period in Turkey: secular trend towards earlier age of onset
  16. Relationships of gamma-glutamyltransferase and beta 2-microglobulin on high sensitivity C-reactive protein among Japanese elementary school children
  17. Evaluation of insulin resistance and metabolic syndrome in a group of obese Czech children
  18. Circulating intact parathyroid hormone is suppressed at 25-hydroxyvitamin D concentrations >25 nmol/L in children
  19. Association between vitamin D level and cardiovascular risk in obese children and adolescents
  20. Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents
  21. Clinical features at diagnosis and responses to antithyroid drugs in younger children with Graves’ disease compared with adolescent patients
  22. Influence of hormonal parameters, bone mineral density and bone turnover on fracture risk in healthy male adolescents: a case control study
  23. Evaluation of lipid and glucose metabolism and cortisol and thyroid hormone levels in obese appropriate for gestational age (AGA) born and non-obese small for gestational age (SGA) born prepubertal Slovak children
  24. Chitotriosidase as a possible marker of clinically evidenced atherosclerosis in dyslipidemic children
  25. Exhaled carbon monoxide in adolescents with diabetic cardiovascular autonomic neuropathy
  26. Gut hormone profiles in preterm and term infants during the first 2 months of life
  27. Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective chart review
  28. A deletion including exon 2 of the TSHR gene is associated with thyroid dysgenesis and severe congenital hypothyroidism
  29. Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) in childhood
  30. Patient Reports
  31. Neonatal diabetes in an infant of diabetic mother: same novel INS missense mutation in the mother and her offspring
  32. Atypical neurologic presentations of new onset type 1 diabetes mellitus in pediatric age group: a report of five unusual cases and review of the literature
  33. Importance of dietary calcium and vitamin D in the treatment of hypercalcaemia in Williams-Beuren syndrome
  34. Vitamin D intoxication in two brothers: be careful with dietary supplements
  35. Transient diabetes insipidus in a preterm neonate and the challenge of desmopressin dosing
  36. A rare case of hypoglycaemia due to insulinoma in an adolescent with acutely altered mental status
  37. Holoprosencephaly: ZIC2 mutation in a case with panhypopituitarism
  38. An association of hypochondroplasia and immune deficiency
  39. Hypophosphatemic rickets caused by a novel PHEX gene mutation in an Indian girl
  40. Psoriasis vulgaris and autoimmune polyendocrine syndrome type I: a case report
  41. Identification of a combined missense/splice-site mutation in FAH causing tyrosinemia type 1
  42. Letter to the Editor
  43. Vitamin D intake and premature infants with intraventricular hemorrhage: how advisable is it?
Downloaded on 24.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0401/html
Scroll to top button